Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
9/23/2022
IQVIA: Chinese Retail Pharmacy Sales Fell 3.8% in Q2/2022
9/23/2022
SMEI: Chinese Retail Pharmacy O2O Development Report 2022
9/23/2022
Drug R&D and Product Registration News Digest September 2022 (3)
9/23/2022
Recent Executive Moves
9/22/2022
Moderna 'Eager' to Collaborate with China on Supplying COVID Vaccines
9/22/2022
SCHOTT Pharma Expands Cartridge Production in China and Hungary
9/22/2022
Merck Group Opens Shanghai Biologics Testing Center to Cater for Local...
9/22/2022
Amgen Marks Ten Years in China, Set to Speed Up Domestic Growth
9/22/2022
The Chosen Few: A Fresh Look at European FDI in China (Rhodium)
9/22/2022
China Bets Big on Brain Research with Massive Cash Infusion and Openne...
9/22/2022
COVID Is Undermining China's Bold Plan for Universal Health Care (Nikk...
9/21/2022
Drug R&D and Approvals in China – August Update on YouTube (PharmCube...
9/21/2022
China Approved Its First Homegrown CD20 Antibody in August (PharmaDJ)
9/21/2022
Merck China President Allan Gabor Shares Insights on AI and Biomedicin...
9/21/2022
NHC: China to Become A Severely-aging Society by 2035, Posing Challe...
9/21/2022
F-star Therapeutics Discloses Extended CFIUS Review for Sino-Biopharma...
9/21/2022
Roche and Ascletis Pharma Terminate Promotion Agreement for Pegasys i...
9/21/2022
PhIIC: Chinese Hospital Drug Sales Fell 4.85% in Q2/2022
9/21/2022
Inventiva and Sino Biopharm Enter Licensing Pact for Lanifibranor i...
9/20/2022
Immuno Cure BioTech Acquires Shanghai Teresa Healthcare
9/20/2022
SCMP: Biden's Biotech Plan Has Limited Near-Term Impact on Chinese Fir...
9/19/2022
NHSA Announces the List of Drugs Passing Preliminary Form Evaluation f...
9/19/2022
CDE Solicits Comments on the Draft Technical Guidelines of Quantitativ...
9/16/2022
METiS Enters License Agreement with Voronoi for Pan-RAF Inhibitor
9/16/2022
Top Ten Listed Chinese Medpharm Cos by R&D Investment in H1/2022
9/16/2022
MOFCOM: Review of Pharmaceutical Distribution Industry Performance in ...
9/16/2022
Competition Intensifies as More Chinese Regions Embarks on Free HPV Va...
9/16/2022
Recent Executive Moves
9/16/2022
Drug R&D and Product Registration News Digest September 2022 (2)
9/16/2022
Chinese Pharma Companies Raised Over $500M in August (PharmaDJ)
Page:
71
/
719
Total number of articles:
21546
:
[First]
[<<]
[69]
[70]
[71]
[72]
[73]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit